When comparing the expression of four erythroblast surface markers between 53 undeniable MDS patients and 46 control participants, Mathis et al. identified that the coefficients of variation (CV) of the fluorescence intensity of CD71 and CD36 are highly sensitive and robust discriminative tools for MDS diagnosis (see Figure 8) (38). This evidence concerns the gene CD36 and myelodysplastic syndrome.